Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.19.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2019
Dec. 31, 2018
Assets    
Equity method investments $ 449,304 $ 471,044
Real estate 363,037 365,370
Investments 113,177 169,793
Cash and cash equivalents 186,152 21,418
Other assets 192,893 182,628
Total Assets 2,279,168 2,154,913
Liabilities:    
Accounts payable, accrued expenses and other 39,851 36,509
Deferred funding obligations 1,073 72,100
Credit facilities 37,824 258,592
Non-recourse debt (secured by assets of $887 million and $1,105 million, respectively) 664,722 834,738
Senior unsecured notes 505,513 0
Convertible notes 147,642 148,451
Total Liabilities 1,396,625 1,350,390
Stockholders’ Equity:    
Preferred stock, par value $0.01 per share, 50,000,000 shares authorized, no shares issued and outstanding 0 0
Common stock, par value $0.01 per share, 450,000,000 shares authorized, 64,924,800 and 60,510,086 shares issued and outstanding, respectively 649 605
Additional paid in capital 1,063,102 965,384
Accumulated deficit (193,121) (163,205)
Accumulated other comprehensive income (loss) 8,746 (1,684)
Non-controlling interest 3,167 3,423
Total Stockholders’ Equity 882,543 804,523
Total Liabilities and Stockholders’ Equity 2,279,168 2,154,913
Government Receivables [Member]    
Assets    
Receivables 299,877 497,464
Commercial Receivables [Member]    
Assets    
Receivables $ 674,728 $ 447,196